Comparison of Two Liraglutide Formulations in Healthy Subjects

NCT01515579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: liraglutide
DRUG: liraglutide

Sponsor

Novo Nordisk A/S